Michael Haude

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial

Raimund Erbel, Carlo Di Mario, Jozef Bartúnek et al. · The Lancet · 2007 · 895 citations

Coronary Arteries, Percutaneous Coronary Intervention, Cardiovascular Disease +10

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek et al. · The Lancet · 2014 · 556 citations · Full text

Percutaneous Coronary Intervention, Absorb Ii, Endovascular Technique +11

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi et al. · The Lancet · 2016 · 534 citations · Full text

Percutaneous Coronary Intervention, Absorb Ii, Everolimus-eluting Metallic Stent +10

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Michael Haude, Raimund Erbel, Paul Erné et al. · The Lancet · 2013 · 419 citations

Percutaneous Coronary Intervention, Engineering, De-novo Coronary Lesions +5

High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P ₃ Lysophospholipid Receptor

Gregor Theilmeier, Christoph Schmidt, Jörg Herrmann et al. · Circulation · 2006 · 411 citations · Full text